Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
christian_eggeling

Prof Christian Eggeling with Prof Simon Davies and Dr Jan Rehwinkel, MRC Human Immunology Unit (HIU), have just been awarded a Multi-user Equipment Grant from the Wellcome Trust. This is for upgrades to two existing super-resolution STED microscopes that form part of the Wolfson Imaging Centre Oxford, under supervision of Prof Christian Eggeling and Dr Christoffer Lagerholm. The upgrades will enable users to take super-resolved images in three dimensions rather than two and will enable multi-colour detection. This represents a superb advance for researchers, in the questions that can now be addressed by STED microscopy. The two microscopes to be upgraded are the Leica SP8 STED system situated in the Imaging Centre Room 1 and the RESOLFT/STED system sited in a dedicated Containment Level 3 room in HIU. This latter upgrade will allow the study of highly infectious pathogens such as HIV in living cells. The value of the award is £281K with an additional 10% being supported by the Director’s Fund and Christian Eggeling’s own research funds. The unique upgraded systems will benefit from collaborations and development agreements with companies helping to implement these cutting-edge developments, and will ensure that Oxford and UK researchers have access to the latest super-resolution imaging technology.

Please contact Christian Eggeling or Christoffer Lagerholm if interested in using these new technologies.

 

3DSTEDgrantpublicityfig1
 3DSTEDgrantpublicityfig2

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.